Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diquafosol vs Hyaluronic Acid for Dry Eye After Trans-PRK
NCT06852105Not yet recruiting
- Sponsor
- He Eye Hospital
- Start
- Feb 2025
- Primary completion
- May 2026
- Modality
- Small Molecules
01
Overview
Randomised trial of diquafosol in dry eye syndrome (DED) (2 arms), sponsored by He Eye Hospital. Primary endpoint: Non-invasive tear break-up time at 24 weeks. Planned start Feb 2025; status: not yet recruiting.
02
Drugs
diquafosol
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on NCT06852105.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06852105.